There isn’t a one-off loading dose; instead there’s a gradual dose-escalation (titration) phase. You start low and step up in stages...

After stopping, many people regain some weight over time because appetite signals gradually return toward baseline. How much and how...

After stopping, many people regain some weight over time because appetite signals gradually return toward baseline. How much and how quickly varies, but the pattern is common across all weight-management approaches. Planning ahead helps: keep protein intake consistent, maintain activity that preserves strength, and agree a follow-up plan with your team (for example, a slower taper, maintenance strategies, or alternative support). If you stop because goals have been met, expec

There isn’t a one-off loading dose; instead there’s a gradual dose-escalation (titration) phase. You start low and step up in stages...

Yes — both men and women can use Wegovy when they meet eligibility criteria. Because exposure in pregnancy isn’t recommended, women of...

In UK services, routine age use focuses on adults within specialist pathways. Use in people under 18 is specialist and not part of...

Yes — both men and women can use Wegovy when they meet eligibility criteria. Because exposure in pregnancy isn’t recommended, women of child-bearing potential are advised to use effective contraception and to discuss stopping in advance if planning a pregnancy. If you become pregnant, contact your clinical team promptly to review treatment. Apart from pregnancy and breastfeeding considerations, the approach to dosing and monitoring is similar across genders. Equal access in e

In UK services, routine age use focuses on adults within specialist pathways. Use in people under 18 is specialist and not part of standard adult commissioning routes. If a young person is being considered for treatment, this would happen in paediatric services with multidisciplinary input and careful assessment of risks and benefits. Focus on adults in UK guidance In the UK, Wegovy is commissioned primarily for adults who meet strict eligibility criteria. NICE guidance and c

Clinically important interactions are few, but there are practical considerations. Because Wegovy can slow stomach emptying, the...

Clinically important interactions are few, but there are practical considerations. Because Wegovy can slow stomach emptying, the...

Suitability depends on your health profile, but many people with common conditions like type 2 diabetes or high blood pressure can use...

Suitability depends on your health profile, but many people with common conditions like type 2 diabetes or high blood pressure can use Wegovy within specialist care. If you take insulin or medicines that can cause low blood sugar, your prescriber may adjust doses to reduce hypo risk as appetite changes. Blood-pressure tablets usually continue as normal, with routine monitoring as weight and salt intake shift. People with a history of certain rare endocrine or pancreatic issue

The medicine is intended to sit alongside a reduced-calorie diet and regular movement, not replace them. People usually find it easier to meet protein targets, shrink portions, and cut between-meal snacking when appetite is quieter. Light-to-moderate activity protects muscle while weight comes down, and small daily habits (steps, resistance bands at home, shorter eating windows that suit you) compound gains without feeling punitive. UK services will tailor this mix and adjust

The medicine is intended to sit alongside a reduced-calorie diet and regular movement, not replace them. People usually find it easier to...

Appetite suppression with semaglutide comes from activating GLP-1 receptors in brain regions that govern hunger and satisfaction,...

Appetite suppression with semaglutide comes from activating GLP-1 receptors in brain regions that govern hunger and satisfaction,...

The dosage schedule is once weekly on the same day, using a step-up “titration” plan to reach a maintenance dose. A common pathway starts...

The dosage schedule is once weekly on the same day, using a step-up “titration” plan to reach a maintenance dose. A common pathway starts low (for example, 0.25 mg weekly) and increases in stages (0.5 mg → 1.0 mg → 1.7 mg) toward a usual maintenance dose of 2.4 mg weekly, with each step typically lasting several weeks. If side effects occur, clinicians can extend a step or pause before moving up; this flexibility is standard practice across UK services. People scheduled for p

The primary target is the GLP-1 receptor, found in brain regions that regulate hunger and satiety and in the gut’s signalling pathways....

The primary target is the GLP-1 receptor, found in brain regions that regulate hunger and satiety and in the gut’s signalling pathways....